BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 1695254)

  • 1. Cloning and characterization of human immunodeficiency virus type 1 variants diminished in the ability to induce syncytium-independent cytolysis.
    Stevenson M; Haggerty S; Lamonica C; Mann AM; Meier C; Wasiak A
    J Virol; 1990 Aug; 64(8):3792-803. PubMed ID: 1695254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein.
    Kowalski M; Bergeron L; Dorfman T; Haseltine W; Sodroski J
    J Virol; 1991 Jan; 65(1):281-91. PubMed ID: 1702159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of two distinct cytopathic effects with syncytium formation-defective human immunodeficiency virus type 1 mutants.
    Dedera D; Ratner L
    J Virol; 1991 Nov; 65(11):6129-36. PubMed ID: 1717715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of human immunodeficiency virus type 1 cytopathic effects by replacing a 424-bp region of envelope from a noncytopathic biological clone.
    Forte SE; Somasundaran M; Sullivan JL
    AIDS Res Hum Retroviruses; 2000 Jan; 16(2):125-37. PubMed ID: 10659052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120.
    Cheng-Mayer C; Shioda T; Levy JA
    J Virol; 1991 Dec; 65(12):6931-41. PubMed ID: 1658383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity.
    de Jong JJ; Goudsmit J; Keulen W; Klaver B; Krone W; Tersmette M; de Ronde A
    J Virol; 1992 Feb; 66(2):757-65. PubMed ID: 1731110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variants selected by treatment of human immunodeficiency virus-infected cells with an immunotoxin.
    Pincus SH; Wehrly K; Tschachler E; Hayes SF; Buller RS; Reitz M
    J Exp Med; 1990 Sep; 172(3):745-57. PubMed ID: 1696955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinational analysis of a natural noncytopathic human immunodeficiency virus type 1 (HIV-1) isolate: role of the vif gene in HIV-1 infection kinetics and cytopathicity.
    Sakai K; Ma XY; Gordienko I; Volsky DJ
    J Virol; 1991 Nov; 65(11):5765-73. PubMed ID: 1920615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo evolution of a novel, syncytium-inducing and cytopathic feline leukemia virus variant.
    Rohn JL; Moser MS; Gwynn SR; Baldwin DN; Overbaugh J
    J Virol; 1998 Apr; 72(4):2686-96. PubMed ID: 9525586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression to AIDS in macaques is associated with changes in the replication, tropism, and cytopathic properties of the simian immunodeficiency virus variant population.
    Rudensey LM; Kimata JT; Benveniste RE; Overbaugh J
    Virology; 1995 Mar; 207(2):528-42. PubMed ID: 7886956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttranslational modifications within the HIV-1 envelope glycoprotein which restrict virus assembly and CD4-dependent infection.
    Haggerty S; Dempsey MP; Bukrinsky MI; Guo L; Stevenson M
    AIDS Res Hum Retroviruses; 1991 Jun; 7(6):501-10. PubMed ID: 1931229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization.
    Gao F; Morrison SG; Robertson DL; Thornton CL; Craig S; Karlsson G; Sodroski J; Morgado M; Galvao-Castro B; von Briesen H; Beddows S; Weber J; Sharp PM; Shaw GM; Hahn BH
    J Virol; 1996 Mar; 70(3):1651-67. PubMed ID: 8627686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity.
    Dubay JW; Roberts SJ; Brody B; Hunter E
    J Virol; 1992 Aug; 66(8):4748-56. PubMed ID: 1629954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate.
    Kumar P; Hui HX; Kappes JC; Haggarty BS; Hoxie JA; Arya SK; Shaw GM; Hahn BH
    J Virol; 1990 Feb; 64(2):890-901. PubMed ID: 2296086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization.
    Grimaila RJ; Fuller BA; Rennert PD; Nelson MB; Hammarskjöld ML; Potts B; Murray M; Putney SD; Gray G
    J Virol; 1992 Apr; 66(4):1875-83. PubMed ID: 1548744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syncytium induction in primary CD4+ T-cell lines from normal donors by human immunodeficiency virus type 1 isolates with non-syncytium-inducing genotype and phenotype in MT-2 cells.
    Todd BJ; Kedar P; Pope JH
    J Virol; 1995 Nov; 69(11):7099-105. PubMed ID: 7474129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1.
    Collman R; Balliet JW; Gregory SA; Friedman H; Kolson DL; Nathanson N; Srinivasan A
    J Virol; 1992 Dec; 66(12):7517-21. PubMed ID: 1433527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro.
    Kusumi K; Conway B; Cunningham S; Berson A; Evans C; Iversen AK; Colvin D; Gallo MV; Coutre S; Shpaer EG
    J Virol; 1992 Feb; 66(2):875-85. PubMed ID: 1731112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cloning, expression, and biological characterization of an HTLV-II envelope glycoprotein: HIV-1 expression is permissive for HTLV-II-induced cell fusion.
    Wang B; Agadjanyan MG; Srikantan V; Ugen KE; Hall W; Kaplan MH; Dang K; Williams WV; Weiner DB
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):849-60. PubMed ID: 8257634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages.
    Chesebro B; Nishio J; Perryman S; Cann A; O'Brien W; Chen IS; Wehrly K
    J Virol; 1991 Nov; 65(11):5782-9. PubMed ID: 1920616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.